An anti–PD-1 monoclonal antibody formerly known as BMS-936558 (PMID 23714523). Approximate rate of pneumonitis is circa 3%, of which 1% are severe. Incidence of pneumonitis is higher in those patients on concomitant nivolumab plus ipilumab (PMID 25891304)

Last update : 22/10/2017

Patterns